Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02766582
Title Phase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Medical College of Wisconsin
Indications

fallopian tube cancer

peritoneum cancer

ovary epithelial cancer

Therapies

Carboplatin + Paclitaxel + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.